EUVIMEDEUVIMED entdecken
Crossref

SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice

Fei Yang, Minjie Zhang, Ruyi Xu, Yunhui Yu, Haimei Feng, Dong Li, Ling Li, Biyan Zhang, Gang Liu, Yanping Wang, Qing Xie, Zijun Chen und 2 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Fei Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; Suzhou Pharmavan Co.,Ltd, Suzhou, Jiangsu 215127, Chin…. Hauptthemen laut MEDLINE: Dextran Sulfate, Gastrointestinal Microbiome, Diarylheptanoids, Colitis, Ulcerative. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis, a chronic inflammatory condition affecting the rectum and colon to varying degrees, is linked to a dysregulated immune response and the microbiota. Sodium (aS,9R)-3-hydroxy-16,17-dimethoxy-15-oxidotricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexene-9-yl sulfate hydrate (SDH) emerges as a novel diarylheptane compound aimed at treating inflammatory bowel diseases. However, the mechanisms by which SDH modulates these conditions remain largely unknown. In this study, we assessed SDH's impact on the clinical progression of dextran sodium sulfate (DSS)-induced ulcerative colitis. Our results demonstrated that SDH significantly mitigated the symptoms of DSS-induced colitis, reflected in reduced disease activity index scores, alleviation of weight loss, shortening of the colorectum, and reduction in spleen swelling. Notably, SDH decreased the proportion of Th1/Th2/Th17 cells and normalized inflammatory cytokine levels in the colon. Furthermore, SDH treatment modified the gut microbial composition in mice with colitis, notably decreasing Bacteroidetes and Proteobacteria populations while substantially increasing Firmicutes, Actinobacteria, and Patescibacteria. In conclusion, our findings suggest that SDH may protect the colon from DSS-induced colitis through the regulation of Th1/Th2/Th17 cells and gut microbiota, offering novel insights into SDH's therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dextran SulfateGastrointestinal MicrobiomeDiarylheptanoidsColitis, UlcerativeMice, Inbred C57BLAnimalsMiceColonCytokinesDisease Models, AnimalColitisMaleTh1 CellsTh17 CellsAnti-Inflammatory AgentsTh2 CellsHumans

Stichwörter der Autor:innen

DSS-induced colitisGut microbiotaInflammatory cytokinesTh cellsUlcerative colitis

Substanzen

Dextran SulfateDiarylheptanoidsCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China; Suzhou Pharmavan Co.,Ltd, Suzhou, Jiangsu 215127, China.
  • Suzhou Pharmavan Co.,Ltd, Suzhou, Jiangsu 215127, China.
  • Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China.
  • School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: zjchen21@aliyun.com.cn.
  • Suzhou Pharmavan Co.,Ltd, Suzhou, Jiangsu 215127, China. Electronic address: pharmanal@pharmavan.cn.
  • Institutes of Biology and Medical Sciences, Soochow University, Suzhou, Jiangsu 215123, China. Electronic address: yunsenli@suda.edu.cn.

Zitieren

APA

Yang, F., Zhang, M., Xu, R., Yu, Y., Feng, H., Li, D., Li, L., Zhang, B., Liu, G., Wang, Y., Xie, Q., Chen, Z., Cao, Y., & Li, Y. (2024). SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112234

Vancouver

Yang F, Zhang M, Xu R, Yu Y, Feng H, Li D, et al. SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112234

BibTeX
@article{Yang2024,
  author = {Yang, Fei and Zhang, Minjie and Xu, Ruyi and Yu, Yunhui and Feng, Haimei and Li, Dong and Li, Ling and Zhang, Biyan and Liu, Gang and Wang, Yanping and Xie, Qing and Chen, Zijun and Cao, Yu and Li, Yunsen},
  title = {SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112234}
}
Kostenlos starten →